echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Tasly JS1-1-01 tablets were approved by the US FDA for clinical trials

    Tasly JS1-1-01 tablets were approved by the US FDA for clinical trials

    • Last Update: 2021-09-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On August 2, Tasly issued an announcement stating that its wholly-owned subsidiary Tasly (North America) Pharmaceutical Co.
    , Ltd.
    (referred to as "North American Pharmaceuticals") received the US FDA's approval of the new chemical drug JS1-1-01 tablets for moderate to severe use.
    Notification of clinical trials for the treatment of depression (IND number: 153206)
    .

    The therapeutic biological product "Human Growth Hormone Injection" independently developed by North American Pharmaceuticals was approved by the National Medical Products Administration in June 2019 (Specifications: 4IU/1.
    33mg/1ml/bottle, 10IU/3.
    33mg/1ml/ Support)
    .


    A total of 6 indications have been approved: 1.


    This product is based on the original two specifications on the market, this time it has been approved by the National Medical Products Administration to add two new specifications: 6IU/2mg/0.
    6ml/bottle and 8IU/2.
    66mg/0.
    8ml/bottle
    .


    So far, a total of 4 specifications of human growth hormone injection from North American Pharmaceuticals have been approved for marketing


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.